Women who receive false-positive results from routine breast cancer screenings may experience a low quality of life and feelings of anxiety for at least one year, according to a study published online Dec. 20 in the British Journal of Surgery.
TUESDAY, Jan. 25 (HealthDay News) -- Women who receive false-positive results from routine breast cancer screenings may experience a low quality of life and feelings of anxiety for at least one year, according to a study published online Dec. 20 in the British Journal of Surgery.
Alida F.W. van der Steeg, M.D., from the St. Elisabeth Hospital in Lilburg, Netherlands, and colleagues conducted a longitudinal study, measuring the quality of life of 385 women diagnosed with breast disease, between September 2002 and January 2007. Of these women, 152 were correctly diagnosed with breast cancer and 233 women had false-positive mammogram results. Anxiety and quality of life were assessed in these women before diagnosis and during the 12 months following.
The researchers found that significantly more histological biopsies were required in the false-positive group. Almost 60 percent of the false-positive group revisited the outpatient clinic during the first year. Women in the false-positive group with the highest scores on trait anxiety scored lowest on the quality-of-life assessment, and they reported more feelings of anxiety, compared to women with lower trait anxiety scores in either the false-positive or breast cancer groups.
"Women deserve more balanced information to help them choose whether or not to accept an invitation for screening mammography. This should not only focus on the supposed benefits, but should include potential side effects, such as increased feelings of anxiety," the authors write.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More